ANAB
AnaptysBio Inc
45.70$
-4.7%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | -126.4% | – | – | |
| – | +2.0% | +0.2% | -1.7% | +0.2% | +0.8% | +0.8% | -0.8% | +1.5% | -0.7% | +0.7% | -41.3% | – | |
| – | +3.9% | +24.9% | -25.5% | +8.5% | -0.1% | +12.0% | +0.8% | -0.9% | -7.1% | +67.2% | -141.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -115.1% | – | – | -1,298.2% | – | – | -138.7% | – | – | |
| – | +72.8% | -90.4% | +22.2% | +6.1% | +651.4% | -86.7% | +11.4% | -69.2% | -91.7% | +1,600.0% | +0.0% | – | |
| – | +60.5% | +39.5% | -103.6% | – | -150.1% | – | +145.2% | +183.7% | -28.8% | -52.4% | -78.4% | – | |
| – | – | – | – | – | – | +870.2% | +1,055.0% | -81.0% | -65.2% | -100.0% | – | – | |
| – | +67.9% | +164.3% | – | +70.0% | -61.3% | -203.7% | +76.6% | -79.4% | +315.1% | – | -8,004.5% | – | |
| – | – | +83.4% | +2.2% | +560.7% | -157.2% | – | – | – | +95.9% | -92.0% | -1,216.0% | – | |
| – | – | – | – | – | – | – | – | – | – | -126.5% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.